HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts

Cervical cancer is one of the most preventable malignancies in oncology, yet it remains the 4th most common form of cancer among women and continues to account for hundreds of thousands of deaths worldwide.¹ Persistent infection with oncogenic human papillomavirus (HPV) is one of the leading causes of cervical cancer, creating a uniquely actionable pathway for prevention through vaccination and early detection.² Over several decades, HPV vaccination programs and population-based screening efforts have led to substantial reductions in cervical cancer incidence, and scientific evidence supporting these strategies is robust^.2,3 However, significant logistical, socioeconomic, and educational barriers to access have hindered widespread vaccination, thereby limiting these gains.²